###### What is already known?

-   Aerobic physical activity positively impacts blood lipids, however lack of time and enjoyment are cited as impediments to exercising.

-   High-intensity interval training (HIIT) appears to offer greater benefits compared with moderate intensity continuous training (MICT). Protocols are formulated to require less time spent training, however higher intensity may negatively impact enjoyment.

-   Sufficient volume of aerobic physical activity is necessary to induce changes to blood lipids, however little agreement exists as to whether the shorter session duration of high-low intensity intervals or the moderate intensity of longer session steady-state exercise best changes effect size.

###### What are the new findings?

-   HIIT does not out-perform MICT in positively affecting total cholesterol (TC), triglycerides (TRG), low-density lipoprotein cholesterol (LDL-C) and the TC/high-density lipoprotein cholesterol (HDL-C) ratio. However, MICT seems to be inferior to HIIT for inducing positive changes to HDL-C.

-   Participant (age, gender and presence of Metabolic Syndrome (MetS) or MetS factors/risk) and intervention (weight-bearing) characteristics do appear to influence effect size.

-   The multiplicity of HIIT protocols is an obstacle to endorsing a specific HIIT regime most effective for positively impacting blood lipids while accounting for time and enjoyment needs, although HIIT could be chosen in preference to MICT for improving HDL-C.

Introduction {#s1}
============

An abnormally elevated or lowered blood lipid profile, known as dyslipidaemia, is a significant risk factor of cardiovascular disease (CVD)[@R1]; ischaemic stroke[@R3]; non-alcoholic fatty liver disease (NAFLD)[@R4]; and chronic pancreatitis.[@R5] Dyslipidaemia frequently coexists with other Metabolic Syndrome (MetS) factors such as obesity (Ob)[@R7] and type 2 diabetes (T2D)[@R8]; and MetS is implicated in CVD risk.[@R10] Moderate-intensity and vigorous-intensity aerobic physical activity positively impacts MetS factors, thus lowering CVD risk.[@R11] Studies[@R13] and systematic reviews[@R15] have shown aerobic exercise reduces elevated total cholesterol (TC), triglycerides (TRG) and low-density lipoprotein cholesterol (LDL-C) and increases high-density lipoprotein cholesterol (HDL-C) in subclinical and clinical populations.

Much published work has examined and confirmed the beneficial physiological effects of aerobic physical activity or moderate intensity (55%--70% of maximal heart rate (MHR), rate of perceived effort (RPE) of 11--13 on the Borg scale)[@R17] continuous training, known as MICT. The WHO recommends a minimum of 150 min per week of aerobic physical activity at moderate continuous intensity, or 75 min at higher intensity, to maintain or achieve health. However, WHO reports insufficient aerobic physical activity levels among adults\>18 years.[@R18] Poor adherence to such recommended aerobic activity or MICT protocols results from lack of time,[@R19] and lack of support.[@R20] Although enjoyment of exercise is positively associated with incidence of physical activity in adults, absence of enjoyment has not been significant in explaining lack of exercise, and attitudes towards exercise lack positive association with incidence of aerobic physical activity.[@R21] Such findings have prompted searches for alternatives to MICT in order to address continuing insufficient aerobic physical activity levels.

High intensity interval training (HIIT) is a protocol of short work intervals\<60 s--8 min[@R22] of vigorous (70%--90% MHR or RPE Borg scale 14--16)[@R17] to high intensity (≥90% MHR or ≥RPE Borg scale 17)[@R17] interspersed with active (40%--70% MHR or RPE Borg scale 8--13)[@R17] or passive (cessation of movement) recovery periods of 1--5 min.[@R22] HIIT has been employed since the mid-20th century to improve athletic exercise performance.[@R22] Contemporary protocols developed for non-athletes are intended to reduce session time and provide a greater stimulus for physiological and psychological adaptation compared with MICT.

HIIT has been shown to increase peak oxygen consumption (VO~2MAX~ or VO~2PEAK~) compared with MICT in cardiovascular disease (CVD) populations,[@R23] despite VO~2MAX~ being only one component of positive changes to cardiorespiratory fitness.[@R24] Studies indicate that a positive impact on biomedical health indices is protocol dependent in clinical[@R25] and healthy[@R26] populations.

To encourage individuals to undertake aerobic physical activity, both HIIT[@R27] and MICT[@R28] are promoted as enjoyable and effective, although no consensus exists as to which aerobic exercise protocol is more so. Studies have shown a minimum volume of weekly aerobic exercise for a minimum duration[@R29] and a weekly aerobic exercise energy expenditure (EEE) threshold of 1200--2200 kcal[@R30] is necessary to induce positive changes to lipids. Systematic reviews and meta-analyses of the effect of aerobic physical activity on lipid levels have established that longer intervention and session duration results in greater effects.[@R31]

A systematic review comparing HIIT against MICT found no difference on blood lipids in healthy and clinical populations, but no meta-analysis was conducted.[@R33] A pooled analysis comprising only three studies and consisting of CVD, MetS and overweight populations unsurprisingly showed equivocal effects on serum lipids.[@R34] Other systematic reviews[@R16] and meta-analyses[@R15] have investigated the effect of exercise on lipids, but have not compared HIIT against MICT. Thus no previously published meta-analysis exists that has examined the effects of HIIT versus MICT on lipids in subclinical populations.

The aim of this study was therefore to conduct a systematic review and meta-analysis comparing the effects of HIIT and MICT on TC, TRG, HDL-C, LDL-C and TC/HDL-C in subclinical populations and to examine whether one protocol surpassed the other.

Methods {#s2}
=======

This systematic review and meta-analysis was registered in the International Prospective Register of Systematic Reviews.[@R41] Its results are presented according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement.[@R42]

Search strategy {#s2-1}
---------------

GW and NS conducted systematic English-language searches of PubMed, all EBSCO health and medical databases including SPORTDiscus, MEDLINE and CINAHL, as well as Web of Science and EMBASE from inception to September 2019.

Searches included a mix of MeSH and free text terms relevant to the concepts of: exercise training intensity for example, (high OR HIIT OR sprint OR SIT OR vigorous AND moderate continuous OR MICT OR moderate intensity continuous exercise (MICE) OR continuous moderate exercise (CME)); interval training for example, (intermittent OR interval OR reps AND training OR exercise); intervention duration for example, (weeks NOT single bout); exercise-induced lipid metabolism; metabolic syndrome for example, (metabolic syndrome OR MetS OR T2D OR diabetes OR hypertension OR overweight OR obese); and blood lipids for example, (lipids OR cholesterol OR lipoprotein OR triglycerides). Searches excluded for pregnancy, lactation, elite athletes, juveniles, CVD, stroke, cancer and NAFLD. Systematic reviews and reference lists of papers were hand searched for additional studies.

Participants and interventions inclusion/exclusion criteria {#s2-2}
-----------------------------------------------------------

Subclinical (healthy or overweight or MetS or MetS factors such as hypertensive), and clinical (Ob and T2D) participants taking usual medications, and with a sample size population of n≥5 in HIIT and MICT groups were included.

Two distinct exercise protocols differentiated by effort as per established guidelines[@R17] and described as either steady state (MICT) or higher effort plus active or passive recovery intervals (HIIT), separate to warm up and cool-down, were required. No restrictions were placed on exercise session time, number and time length of work and recovery intervals or exercise type. Levels and measurement of effort such as percentage of VO~2PEAK~ or VO~2MAX~, percentage of peak heart rate (HR~PEAK~) or MHR or heart rate reserve or individual anaerobic threshold heart rate (HR~IAT~), Borg scale, metabolic equivalent (MET), or percentage of workload or watts (W~MAX~ or W~PEAK~) were required. Resistance-training or combined-training interventions without separate HIIT and MICT interventions as comparators were excluded.

Comparator {#s2-3}
----------

HIIT protocols as the intervention were compared against MICT protocols as the control for differentiated impacts on blood lipids.

Outcomes {#s2-4}
--------

Pre--post intervention lipid measurements reported as mmol/L or mg/dL for any of TC, TRG, HDL-C, LDL-C or TC/HDL-C were required.

Study selection {#s2-5}
---------------

GW and NS assessed the resulting titles and abstracts of randomised controlled trials (RCTs) lasting ≥4 weeks, which compared HIIT and MICT protocols, and reported pre--post intervention lipid measurements in humans≥18 years. Subsequently, the full text of potentially eligible studies was reviewed according to participant, intervention and outcome inclusion and exclusion criteria. TvdT was consulted to resolve disputes. The flow of papers through the search and inclusion process is presented in [figure 1](#F1){ref-type="fig"}.

![PRISMA flow diagram adapted from Moher *et al.*[@R42] PRISMA, Preferred Reporting Items for Systematic Reviews and Meta-Analyses.](bmjsem-2019-000647f01){#F1}

Data extraction {#s2-6}
---------------

GW and AM extracted the data to a pre-established extraction form and NS and TvdT confirmed the data extraction. For each study the following information was extracted: (1) author(s), year of publication and study design characteristics, (2) demographic and clinical characteristics, (3) HIIT intervention and MICT control protocols, (4) values before and after HIIT intervention and MICT control for any of TC, TRG, HDL-C, LDL-C or TC/HDL-C ratio and expressed as mean (M) or mean difference (MD), SD or converted to SD (SE using SD=square root (Sample Size) x SE), as well as main findings concerning lipids.

Data synthesis {#s2-7}
--------------

Statistical analyses were performed using Revman V.5.3 (The Nordic Cochrane Centre, Copenhagen, Denmark) for continuous data by using the MD and SD of the MD. Where the MD and SD of the MD were not reported, the MD was calculated by subtracting the preintervention M from the postintervention M. The SD of the MD was calculated as follows: SD=square root \[(SD~pre-treatment~)^2^ + (SD~post-treatment~)^2^ -- (2 r x SD~pre-treatment~ x SD~post-treatment~)\], assuming a correlation coefficient (r)=0.5, considered a conservative estimate.[@R43] Revman V.5.3 also enabled calculations of the SD of the MD using group sample size and p values or 95% CIs when provided. Where data was not presented in text or tables and authors could not be reached, data presented in figures was extracted where possible.

Data were pooled for meta-analysis when two or more studies measured the same outcome and provided data in a format suitable for pooling. Where a study included multiple HIIT groups, data were entered separately for each group and the sample size of the MICT group was divided by the number of HIIT groups to eliminate inflation of the sample size. GW entered the data in Revman V.5.3; TvdT reviewed the data entry for accuracy. A random effects inverse variance model was used with the effects measure of MD, a 5% level of significance and a 95% CI to report change in outcome measures. This model was chosen to allow for different effect sizes achieved across selected studies.[@R44]

Meta-analysis and subanalyses {#s2-8}
-----------------------------

For meta-analysis of the four cholesterol fractions and single ratio, all included studies were grouped under each fraction and data was pooled. Subanalyses were conducted according to: age; gender; presence or absence of MetS risk and/or factor(s) or T2D; and weight-bearing or non-weight-bearing exercise.

Sensitivity analysis {#s2-9}
--------------------

In order to evaluate the influence of each study on the overall effect size of pooled data, we conducted iterative leave-one-out sensitivity analyses.[@R45] Where subanalyses gave rise to significance, iterative leave-one-out analysis (K−1, where K=the number of studies, and each study is excluded from the pool analysis one at a time) was also conducted.

Heterogeneity and publication bias {#s2-10}
----------------------------------

Heterogeneity was quantified using the I^2^ test where heterogeneity values range from 0% (homogeneity) to 100% (complete heterogeneity).[@R46] Visual inspection of funnel plots was used to assess risk of publication bias.[@R47] If the 95% CIs of a study were outside the pooled 95% CIs, the study was removed as an outlier.[@R48]

Study quality {#s2-11}
-------------

Study quality was assessed by AM and GW and reviewed by NS and TvdT, using the validated Tool for the Assessment of Study Quality and Reporting in Exercise (TESTEX),[@R49] a 15-point scale specific to exercise training studies. A score ≥10 indicates a better study quality and reporting. In the case of discrepancies NS was consulted. A study quality subanalysis of studies grouped according to TESTEX scores (≥10,\<10) was also conducted.

Results {#s3}
=======

Combined searches generated a total of 126 articles. After removal of duplicates and exclusion of articles based on abstract and title, 37 full-text articles remained for screening. One study using a non-HIIT protocol,[@R50] two studies using dietary intervention,[@R51] two studies of increasing intensity not high-intensity intervals,[@R13] one study with no MICT group,[@R54] one study reporting only preintervention values,[@R55] one study combining outcome measures of both protocols,[@R56] and a feasibility study[@R57] were excluded. One study tested two HIIT protocols, one of which was excluded.[@R58] Two further excluded studies were non-RCTs.[@R59] Three studies[@R61] tested two HIIT protocols against the same group of MICT participants, hence after screening, a total of 29 data sets from 26 studies[@R24] met the stated inclusion criteria.

Study, participant, and intervention characteristics {#s3-1}
----------------------------------------------------

Summarised descriptions of studies, participants and interventions included in trials are provided in [Table 1](#T1){ref-type="table"} below and detailed descriptions in [online supplementary file 1](#SP1){ref-type="supplementary-material"}.
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###### 

Studies and PICO

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Study (A--Z)                      Participants\       Exercise type,\                                         Sessions week^-1^   Weeks   Outcomes
                                    N, status, gender   HIIT work interval intensity, MICT intensity                                        
  --------------------------------- ------------------- ------------------------------------------------------- ------------------- ------- ------------------------------------
  Ciolac *et al*[@R64]              22 healthy ♀        Treadmill walking or running\                           3                   16      TC, TRG, HDL-C, LDL-C
                                                        HIIT: 80%--90% VO~2MAX~, MICT: 60%--70% VO~2MAX~                                    

  Connolly *et al*[@R65]            30 healthy ♀        Ergocycle\                                              3                   12      TC, TRG, HDL-C, LDL-C, TC/HDL-C
                                                        HIIT: 30--\<100% sprint, MICT: 70%--85% HR~PEAK~                                    

  Cuddy *et al*[@R66]               27 Ov--Ob ♀♂        Ergocycle\                                              HIIT: 2--4\         8       TRG, HDL-C
                                                        HIIT: 100% sprint; MICT: 40%--65% HRR                   MICT: 3--5                  

  Fisher *et al*[@R76]              23 Ov--Ob ♂         Ergocycle\                                              HIIT: 3\            6       TC, TRG, HDL-C, LDL-C
                                                        HIIT: 85% sprint, MICT: 55%--65% VO~2PEAK~              MICT: 5                     

  Hwang *et al*[@R67]               29 Ov ♀♂            All-extremity ergometer\                                4                   8       TC, TRG, HDL-C, LDL-C
                                                        HIIT: 90% HR~PEAK~, MICT: 70% HR~PEAK~                                              

  Keating *et al*[@R68]             22 Ov ♀♂            Ergocycle\                                              3                   12      TC, TRG, HDL-C, LDL-C
                                                        HIIT: 120% VO~2PEAK~, MICT: 50%--65% VO~2PEAK~                                      

  Kemmler *et al*[@R24]             65 Ov--MetS ♂       Running\                                                2--4                16      TRG, HDL-C
                                                        HIIT: 95%--110% HR~IAT~\*, MICT: 70%--82.5% HR~IAT~\*                               

  Kong *et al*[@R69]                26 Ob♀              Ergocycle\                                              4                   5       TC, TRG, HDL-C, LDL-C
                                                        HIIT: max VO~2PEAK~, MICT: 60%--80% VO~2PEAK~                                       

  Lee, *et al* a[@R61]              20 healthy ♂        Ergocyle\                                               3                   4       TC, TRG, HDL-C, LDL-C
                                                        HIIT: 85%--90% VO~2MAX~, MICT: not stated                                           

  Lee, *et al* b[@R61]              18 healthy ♂        Ergocycle\                                              3                   4       TC, TRG, HDL-C, LDL-C
                                                        HIIT: 85%--90% VO~2MAX~, MICT: not stated                                           

  Lira *et al*[@R70]                20 healthy ♂        Treadmill\                                              3                   5       TC, TRG, HDL-C
                                                        HIIT: 100% sVO~2PEAK~, MICT: 70% sVO~2PEAK~                                         

  Maillard *et al*[@R77]            16 Ov--Ob, T2D♀     Ergocycle\                                              2                   16      TC, TRG, HDL-C, LDL-C, TC/HDL-C
                                                        HIIT: 80% MHR, MICT: 55%--60% target HR                                             

  Matsuo *et al*[@R75]              26 Ov--MetS ♂       Ergocycle\                                              3                   8       TC, TRG, HDL-C, LDL-C, TC/HDL-C
                                                        HIIT: 85% VO~2PEAK~, MICT: 60%--65% VO~2PEAK~                                       

  Mohr *et al*[@R71]                42 hours, Ov ♀      Free-style swimming\                                    3                   15      TC, HDL-C, LDL-C
                                                        HIIT: 85%--95% MHR, MICT: 72%--79% MHR                                              

  Morales-Palermo *et al* a[@R62]   50 MetS♀♂           Ergocycle\                                              3                   16      TC, TRG, HDL-C, LDL-C
                                                        HIIT4: 90% MHR, MICT: 70% MHR                                                       

  Morales-Palermo *et al* b[@R62]   49 MetS♀♂           Ergocycle\                                              3                   16      TC, TRG, HDL-C, LDL-C
                                                        HIIT1:100% MHR, MICT: 70% MHR                                                       

  Moreira *et al*[@R72]             16 Ob ♀♂            Ergocycle\                                              3                   12      TC, TRG
                                                        HIIT: 60%--72% VO~2MAX~, MICT: 55%--66% VO~2MAX~                                    

  Nybo *et al*[@R73]                17 healthy ♂        Running\                                                3                   12      TC, HDL-C, LDL-C, TC/HDL-C
                                                        HIIT: 85% VO~2MAX~, MICT: 65% VO~2MAX~                                              

  Ramos *et al*[@R58]               32 MetS, T2D ♀♂     Walking/running, ergocycle/cycling, swimming\           HIIT: 3\            16      TRG, HDL-C
                                                        HIIT: 85%--95% HR~PEAK~, MICT: 60%--70% HR~PEAK~        MICT: 5                     

  Ruffino *et al*[@R78]             16 Ov--Ob, T2D ♂    Ergocycle, walking\                                     HIIT: 3\            8       TRG, HDL-C, LDL-C
                                                        HIIT: 80%--90% MHR, MICT: 50%--55% HRR                  MICT: 5                     

  Sawyer *et al*[@R79]              18 Ob ♀♂            Ergocycle\                                              3                   8       TC, TRG, HDL-C, LDL-C
                                                        HIIT: 90%--95% MHR, MICT: 70%--75% MHR                                              

  Shepherd *et al*[@R74]            78 Ov ♀♂            Ergocycle\                                              HIIT: 3\            10      TC, TRG, HDL-C, LDL-C, LDL-C/HDL-C
                                                        HIIT:\>90% MHR, MICT: 70% MHR                           MICT: 5                     

  Thomas *et al* a[@R63]            14 healthy ♂        Running\                                                3                   11      TC, HDL-C
                                                        HIIT: 90%--100% MHR, MICT: 75%--85% MHR                                             

  Thomas *et al* b[@R63]            14 healthy ♂        Running\                                                3                   11      TC, HDL-C
                                                        HIIT: 90%--100% MHR, MICT: 75%--85% MHR                                             

  Tjønna *et al*[@R55]              19 MetS ♀♂          Treadmill walking and running\                          3                   8       TRG, HDL-C
                                                        HIIT: 90% MHR, MICT: 70% MHR                                                        

  Vella *et al*[@R25]               17 Ov--Ob ♀♂        Treadmill, ergocycle, elliptical\                       4                   8       TC, TRG, HDL-C, LDL-C
                                                        HIIT: 75%--80% HRR, MICT: 55%--59% HRR                                              

  Winding *et al*[@R80]             25 Ov, T2D ♀♂       Ergocycle\                                              3                   11      TC, TRG, HDL-C, LDL-C
                                                        HIIT: 95% W~PEAK~, MICT: 50% W~PEAK~                                                

  Winn *et al*[@R81]                16 Ob ♀♂†           Treadmill walking and running\                          4                   4       TC, TRG, HDL-C, LDL-C
                                                        HIIT: 80% VO~2PEAK~, MICT: 55% VO~2PEAK~                                            

  Zhang *et al*[@R82]               24 Ob ♀             Treadmill running\                                      4                   12      TC, TRG
                                                        HIIT: 50%--95% HR~PEAK~, MICT: 60%--70% HR~PEAK~                                    
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

\*HR~IAT~---HR at indvidual aerobic thershold IAt (minimum lactate 2.0 mmol/L).

†Assumed. Gender not specified.

HDL-C, High-density lipoprotein cholesterol; HIIT, High intensity interval training; HR, Heart rate; HR~PEAK~, Peak heart rate; HRR, Heart rate reserve; IAT, individual anaerobic threshold; LDL-C, Low-density lipoprotein cholesterol; MetS, Metabolic Syndrome; MHR, maximal heart rate; MICT, Moderate intensity continuous training; Ob, Obesity; Ov, Overweight; PICO, Participants, Intervention, Comparator, Outcome; TC, Total cholesterol; T2D, Type 2 diabetes mellitus; TRG, Triglycerides; VO~2PEAK,~VO~2MAX~, Peak oxygen consumption; W~PEAK~, Workload or watts.

Comparative outcome measures {#s3-2}
----------------------------

### Total cholesterol {#s3-2-1}

Twenty-one studies of 24 data sets with a total of 653 (352 HIIT, 301 MICT) subjects reported on TC MD (0.10 mmol/L (−0.03 to 0.22), p=0.12, I^2^=0%), shown in [figure 2](#F2){ref-type="fig"}. No significance was found. Sensitivity analysis (K−1) did not change results.

![Total cholesterol. MD and SD expressed as mmol/L; Total = number of participants. HIIT, high intensity interval training; MICT, moderate intensity continuous training, MD, mean difference.](bmjsem-2019-000647f02){#F2}

Subanalyses did not change significance, see [online supplementary files table 2](#SP1){ref-type="supplementary-material"}.

### Triglycerides {#s3-2-2}

Twenty-three studies of 25 data sets with a total of 736 (392 HIIT, 344 MICT) subjects reported on TRG MD (−0.05 mmol/L (−0.11 to 0.01), p=0.10, I^2^=0%), shown in [figure 3](#F3){ref-type="fig"}. No significance was found. Sensitivity analysis (K−1) did not alter significance.

![Triglycerides. MD and SD expressed as mmol/L; Total = number of participants. HIIT, high intensity interval training; MICT, moderate intensity continuous training, MD. mean difference.](bmjsem-2019-000647f03){#F3}

Subanalyses changed significance in favour of HIIT for (1) age grouping 35--55 years (−0.10 mmol/L (--0.19 to --0.01), p=0.03, I^2^=0%); (2) Mets or MetS factors/risk (−0.10 mmol/L (--0.18 to --0.02), p=0.01, I^2^=0%); and (3) weight-bearing protocols (−0.11 mmol/L (--0.21 to 0.00), p=0.04, I^2^=0%). Sensitivity analysis (K--1) of these these subanalyses resulted in no significance with the removal of one study,[@R24] see [online supplementary files table 2](#SP1){ref-type="supplementary-material"}.

### High-density lipoprotein cholesterol {#s3-2-3}

Twenty-six studies comprising 28 data sets with a total of 739 (384 HIIT, 355 MICT) subjects reported on HDL-C MD (0.07 (0.04 to 0.11), p\<0.0001, I^2^=0%), as shown in [figure 4](#F4){ref-type="fig"}, and favoured HIIT. Removal of one outlier[@R70] did not alter significance. Sensitivity analysis (K--1) resulted in insignificance with the removal of one study,[@R24] HDL-C MD (0.04 mmol/L (0.00 to 0.08), p=0.06, I^2^=0%), see [online supplementary files table 2](#SP1){ref-type="supplementary-material"}.

![High density lipoprotein-cholesterol. MD and SD expressed as mmol/L; Total = number of participants. HIIT, high intensity interval training; MICT, moderate intensity continuous training, MD. mean difference.](bmjsem-2019-000647f04){#F4}

With the exception of age (all) and gender (females), subanalyses remained significant for HIIT. Applying sensitivity analysis (K--1) to subanalyses resulted in insignificance for the weight-bearing grouping only, see [online supplementary files table 2](#SP1){ref-type="supplementary-material"}.

### Low-density lipoprotein cholesterol {#s3-2-4}

Twenty data sets of 580 (313 HIIT, 267 MICT) subjects reported on LDL-C MD (0.05 mmol/L (−0.06 to 0.17), p=0.37, I^2^=0%), shown in [figure 5](#F5){ref-type="fig"}. No significance was found. Sensitivity analysis (K--1) did not change significance.

![Low density lipoprotein-cholesterol. MD and SD expressed as mmol/L; Total = number of participants. HIIT, high intensity interval training; MICT, moderate intensity continuous training, MD. mean difference.](bmjsem-2019-000647f05){#F5}

Subanalyses did not change significance, see [online supplementary files table 2](#SP1){ref-type="supplementary-material"}.

### TC/HDL-C ratio {#s3-2-5}

As shown in [figure 6](#F6){ref-type="fig"}, three studies with a total of 72 subjects reported on the TC/HDL-C ratio MD (−0.03 mmol/L (−0.36 to 0.29), p=0.85, I^2^=0%).

![TC/HDL-C ratio. MD and SD; Total = number of participants. HDL-C, high-density lipoprotein cholesterol; HIIT, high intensity interval training; MICT, moderate intensity continuous training, MD. mean difference; TC, total cholesterol.](bmjsem-2019-000647f06){#F6}

### Heterogeneity and publication bias {#s3-2-6}

Meta-analyses indicated zero heterogeneity for all lipid fractions, and the TC/HDL-C ratio. Visual inspection of funnel plots showed moderate-to-high likelihood of publication bias for TC and TRG, and low-to-moderate likelihood for HDL-C and LDL-C, see [online supplementary files figures 2-6](#SP1){ref-type="supplementary-material"}.

### Study quality and reporting {#s3-2-7}

A median TESTEX score of 11 out of 15 was obtained (range 7 to 13). TESTEX scores (≥10 or\<10) did not alter significance and heterogeneity, moreover sensitivity analysis (K--1) did not affect these results, see [online supplementary files table 3](#SP1){ref-type="supplementary-material"}. No study was excluded based on its TESTEX score.

### Lipid assessment {#s3-2-8}

Lipid assay details are provided in [online supplementary files table 4](#SP1){ref-type="supplementary-material"}. No study was excluded based on lipid assay reporting.

Discussion {#s4}
==========

Meta-analysis {#s4-1}
-------------

This systematic review and meta-analysis aimed to compare the effects of HIIT and MICT on adult blood lipid profiles in subclinical populations and to examine whether one protocol was superior to the other. Our review is the first to include more than eight trials and compare the effect size of intermittent high--low intensity and continuous moderate intensity in positively altering TC, TRG, HDL-C, LDL-C and the ratio of TC/HDL-C in subclinical populations. Our analysis, of 29 data sets from 26 studies, assessed the effects on lipids of weight-bearing and non-weight bearing HIIT and MICT exercise therapies excluding concurrent dietary or pharmaceutical interventions. Although HIIT and MICT appear to induce positive changes, our analysis did not demonstrate that intermittent high-intensity out-performed continuous moderate-intensity protocols in achieving better lipid outcomes.

Outcome measures {#s4-2}
----------------

### Total cholesterol {#s4-2-1}

We found no statistically significant evidence showing a benefit in favour of HIIT or MICT in reducing TC. Our results are similar to a previous qualitative review comparing exercise with no exercise.[@R33] Our results differ from the findings of others[@R38] whose works did not differentiate for continuous or interval protocols. We also included papers with intervention duration of 4--6 weeks; these are arguably of insufficient duration to effect change.[@R33] MICT has been shown to prioritise fat as a primary substrate fuel in subclinical populations,[@R83] hence it could be reasonably expected that MICT would outperform HIIT. However, a weekly energy expenditure[@R30] or volume[@R15] is required before impacts on lipids can be observed, and a number of included protocols likely fell short of this threshold. We excluded studies including dietary intervention which may have impacted our results.[@R84]

### Triglycerides {#s4-2-2}

We found no difference in effect size between HIIT and MICT in positively altering TRG except for subanalyses. Our results broadly agree with a recent meta-analysis,[@R85] although we excluded trials of cardiac patients. Our results also agree with a previous qualitative review.[@R33] We differ from the work of others,[@R38] possibly because we included mixed populations or because we differentiated for protocol and intensity. A systematic review suggested TRG responded favourably to increased exercise intensity in MetS populations,[@R16] agreeing with a previous meta-analysis,[@R39] and our subanalysis (MetS or MetS factors/risk) found HIIT significantly lowered TRG more than MICT.

### High-density lipoprotein cholesterol {#s4-2-3}

HIIT showed significance compared with MICT for affecting HDL-C, however sensitivity analysis (K--1) contradicted this result. Our findings agree with a previous meta-analysis,[@R39] although this work compared exercise with no exercise only and focussed on overweight and obese populations. We also agree with the results of a recent meta-analysis comparing intensity, although this work focussed on studies of subjects with cardiovascular conditions.[@R85] Our results are dissimilar to other systematic reviews,[@R16] and two (one female and one male) meta-analyses,[@R38] although none of these works compared for intensity. Given the greater impact on cardiorespiratory fitness of HIIT compared with MICT,[@R23] our result is not unexpected, as HIIT would most likely outperform MICT in optimising lipid transport via an improved microvascular capillary network. However, both HIIT and MICT have been shown to equally improve muscle microvascular density.[@R86]

### Low-density lipoprotein cholesterol {#s4-2-4}

We found no significance for preferring HIIT to MICT for positively changing LDL-C. Our findings agree with other meta-analyses.[@R39] We differ from two meta-analyses comparing exercise with no exercise and examining general populations,[@R38] as well as a meta-analysis comparing intensity and examining LDL-C in overweight and obese populations.[@R87] We surmise this is a corollary of our inclusion of studies with healthy participants, although our subanalyses of clinical and subclinical participants did not affect significance. Previous work showing that LDL-C falls when accompanied by weight loss has been corroborated by a later meta-analysis comparing exercise with no exercise in overweight and obese groups.[@R30] A recent meta-analysis of HIIT compared with MICT in these populations showed no preference for either protocol in achieving weight loss.[@R86] Existing higher base levels of lipids in these populations[@R7] may have led to sufficient decrease in LDL-C to demonstrate significance for HIIT protocols.[@R14] According to one systematic review, increasing intensity is required to impact LDL-C,[@R16] hence MICT by its nature should have shown inferiority to HIIT. Insufficient intervention duration and probable similar overall intensity in the protocols of included studies may have obfuscated our results.

### TC/HDL-C ratio {#s4-2-5}

HIIT and MICT were equivalent in reducing TC/HDL-C ratio.

### Clinical significance and future research {#s4-2-6}

Our meta-analysis results indicate HIIT seems to be superior to MICT in affecting HDL-C. Either HIIT or MICT can be prescribed to positively affect TC, TRG, LDL-C and the TC/HDL ratio, as part of efforts to increase exercise participation to meet current aerobic physical activity guidelines.[@R18] Previous studies and reviews suggest a weekly minimum EEE of \>1200 kcals and time commitment \>150 min of aerobic physical activity at vigorous intensity is necessary to positively impact lipids.[@R26] These indicative minimum requirements exceed current weekly aerobic physical activity guidelines of 150 min at moderate intensity or 75 min at vigorous intensity.[@R89] Sharing the results of these studies and reviews may motivate some demographics to participate in and/or increase aerobic physical activity.

Based on the number of HIIT or MICT sessions per week, our included studies generally met the minimum weekly time requirements of current aerobic physical activity guidelines.[@R89] The EEE, effort, session duration and frequency achieved in several studies were unlikely to meet the levels required to positively impact lipids.[@R26] We propose that future research should address the following criteria to ascertain whether HIIT or MICT is better in inducing desirable changes in TC, TRG and LDL-C for varying populations: interventions should aim for duration \>8 weeks (excluding familiarity sessions) as previously established[@R31]; protocols should achieve a weekly EEE threshold \>1200 kcals,[@R30] or minimum session duration and frequency[@R26]; and HIIT interventions should ensure that the overall effort (work:recovery ratio and repetitions) remains at or close to vigorous intensity per session, since higher intensity has been shown to impact more favourably on lipids than lower intensity.[@R13]

### Strengths and limitations in the systematic review and meta-analyses {#s4-2-7}

This review has a number of strengths. To our knowledge, this review and quantitative meta-analysis is the first to compare the effects of intermittent high-intensity and continuous moderate-intensity weight-bearing and non-weight bearing protocols on cholesterol fractions and the TC/HDL-C ratio in healthy, subclinical and clinical adult populations.

Previous systematic reviews did not use the validated exercise study evaluation tool TESTEX[@R48] to measure the quality of included studies. We followed a rigorous inclusion and exclusion protocol to ensure minimisation of confounding factors among the study populations.[@R90]

A major limitation of this review is the relatively small number of studies used in our subanalyses. This is compounded by the varying populations studied and the different exercise protocols (number and length of effort and recovery intervals, intensities, session and intervention duration, session frequency and energy expenditure) used for comparing HIIT against MICT. Some studies did not report all lipid fractions. In addition, reporting of protocol adherence and intensity used objective for example, electronic devices as well as subjective measures for example, Borg scale, self-reported HR, log books, denoted by different indices of intensity (energy expenditure, VO~2MAX~, MHR, METs, Borg scale).

Aerobic physical activity protocols mainly consisted of running, swimming, walking, or cycling, which could have influenced results. While the majority of studies included in the analysis specified intervention duration ≥8 weeks, a small number of included studies used an intervention duration of 4--6 weeks, which may have weakened results.

With respect to data pooling, we measured the difference between preintervention and postintervention means; in cases where the MD SDs were not available, we imputed the SD using pre--post SDs, p values, and 95% CIs, and hence statistical analyses depended on extrapolated data. Our imputation was conservative, and sensitivity analyses (leave-one-out) were conducted. This approach may have weakened results.

The results of our analysis may have been affected because some of the studies measured lipids as secondary and not as primary outcomes. We therefore infer that some studies were perhaps not designed with the primary goal of lipid lowering. In the paragraph on clinical significance above, we have demonstrated that earlier reviews suggest a minimum weekly EEE of \>1200 kcals, thus some of the studies that met our inclusion criteria may have failed to meet the minimum applicable EEE, session duration and session frequency required to positively impact lipids.

Conclusion {#s5}
==========

Pooled analysis indicated that aerobic physical activity intensity did not influence effect size for change in TC, TRG, LDL-C and TG/HDL-C. Change in the effect size of lipids seems to be sensitive to physical activity volume rather than intensity. The exception to this appears to be HDL-C which improved more with HIIT than MICT. Our findings suggest that HIIT protocols do not confer greater improvements in lipid profiles over MICT protocols. Clinicians and allied health specialists should therefore endeavour to encourage people to undertake aerobic physical activity at or above the minimum threshold (about 1200 kcal weekly) as a treatment or prevention strategy likely to be effective in managing lipid profiles and reducing CVD risk.
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